Catherine Jacobson - 21 May 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
21 May 2025
Transactions value $
$0
Form type
4
Filing time
23 May 2025, 16:06:40 UTC
Previous filing
24 May 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jacobson Catherine Director C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK /s/ Adam C. Vandervoort, Attorney-in-Fact 23 May 2025 0001804442

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +17,467 +86% 37,867 21 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -17,467 -100% $0 0 21 May 2025 Common Stock 17,467 Direct F1, F2
transaction TDOC Restricted Stock Units Award $0 +28,986 $0 28,986 22 May 2025 Common Stock 28,986 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 On May 23, 2024, the reporting person was granted 17,467 restricted stock units, vesting in full on May 21, 2025.
F3 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4 The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders.